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Abstract
The immunochromathographic rapid test (IRT) for canine visceral leishmaniasis (CVL) was tested in suspected dogs 
from the urban area of Cuiabá. The performance of IRT was compared with IFT and EIE and the direct parasitological 
test (DPT) as the gold standard. The sample, comprising 45 dogs, was selected by the Zoonosis Control Center. Twenty 
(51%) were male and thirty-four (75.5%) were both mongrel and had an estimated age of less than three years old.  
According to clinical data and lab tests: 10 (26.3%) dogs have been classified as exposed or infected and 18 (47.4%) as 
sick. IRT has achieved the best result for sensibility, 62%, high specificity, 87% and for positive and negative predictive 
values: 83.3% and negative 81.48%, respectively, reinforced by a k coefficient equal to 0.50, representing substantial 
agreement. 
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Resumo
O teste rápido imunocromatográfico (TRI) para leishmaniose visceral canina (LVC) foi testado em cães suspeitos da 
área urbana de Cuiabá. O desempenho do teste foi comparado com RIFI e ELISA e, como padrão ouro, o teste parasi-
tológico direto (TPD). A amostra com 45 cães foi selecionada pelo Centro de Controle de Zoonoses, sendo 23 (51,1%) 
machos, 34 (75,5%) sem raça definida e com idade estimada inferior a três anos. De acordo com os dados clínicos e 
os exames laboratoriais, 10 (26,3%) cães foram classificados como expostos, outros 10 (26,3%) como infectados e 18 
(47,4%) como doentes. O TRI alcançou os melhores resultados quanto à sensibilidade, 62%, elevada especificidade, 87% 
e para os valores preditivos positivo e negativo: 83,30% e 81,48%, respectivamente, consolidado pelo coeficiente Kappa  
igual a 0,50, de concordância moderada. Os resultados confirmaram TRI como um bom preditor de doença e infecção 
para LVC.   
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Introduction
In Brazil, visceral leishamaniasis (VL) is distributed 
in 21 states, and records show an annual average of 
3,600 human cases and 230 deaths (BRASIL, 2009). 
The disease is caused by Leishmania (Leishmania) 
chagasis (MAURICIO; STOHARD; MILES, 2000) 
and it is transmitted by Lutzomyia longipalpis to a 
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great variety of mammals, including animals and 
human beings. Over the past thirty years, VL has 
spread towards the centers of cities in the Northeast, 
Southeast and Middle West Regions, characterizing 
an urbanization process of the disease (BRASIL, 
2006) and dogs (Canis familiaris) have been referred 
to as the main carriers responsible for the persistence 
of VL in these endemic areas (FRANCA-SILVA et 
al., 2003; WORLD HEALTH ORGANIZATION, 
2008). Meanwhile Almeida et al. (2009) pointed out 
the permanence of dogs in the peridomicile and 
the proximity of the residence to the forest are the 
main risk factors for canine infection. All outbreaks 
reported in the scientific literature are associated with 
the presence of seropositive dogs (MOURA et al., 
1999; FRANCA-SILVA et al., 2003), that precedes the 
human infection (ALENCAR, 1961).
Nevertheless the strategy used by Brazil’s Ministry 
of Health (BMH) (2006) for the control of VL includes 
the disposal of seropositives dogs. However it should 
be reconsidered due to the social problems caused 
by dog culling in addition to the replacement of new 
puppies by their owners (COSTA, 2011). Moreover, 
the diagnosis of canine visceral leishmaniasis (CVL) 
is complex, due to broad and nonspecific clinical signs 
and the presence of asymptomatic dogs. Therefore 
the diagnosis of CVL should be conducted using 
an integrated approach considering local residence, 
travels, habits, careful clinical examination and 
accurate laboratory analysis.
Even with the development of new laboratory 
techniques, the diagnosis of CVL remains a challenge 
for veterinarians and authorities responsible for the 
formulation of effective public policies for zoonosis 
control. The BMH performs the following serological 
tests: the indirect fluorescent test (IFT) and the 
enzyme-linked immunosorbent assay (EIE), both 
being reference techniques and manufactured by Bio-
Manguinhos (BRASIL, 2006). 
IFT and EIE are the techniques most commonly 
used for detection of antileishmanial canine antibodies 
(LIRA et al., 2006; BISUGO et al., 2007; SOLANO-
GALLEGO et al., 2009). IFT is highly sensitive and 
specific for detecting dogs with clinical signs of 
CVL, in addition to those infected but seemingly 
healthy (MOURA et al., 1999; TOLEZANO et al., 
2007; ALMEIDA et al., 2009) and the test allows 
quantification of specific antibodies. Although it has 
disadvantages that may harm its performance, such 
as the subjective interpretation and the cross-reacting 
caused by metabolic discords and against Trypanosoma 
cruzi that have long been recognized (CAMARGO; 
REBONATO, 1969), there is still a lack of consensus 
regarding the threshold titer (DESJEUX, 1996).
EIE is a test with a medium-high sensibility and 
specificity that increase, depending on the antigens 
employed (SOLANO-GALLEGO et al., 2009). The 
best results were obtained when recombinant antigens 
were used (MIRÓ et al., 2008; MARCONDES et al., 
2011), as K39 (CARVALHO et al., 2003; PORROZZI 
et al., 2007). Recombinant K39 antigen is a marker 
of active infection in human visceral leishmaniasis 
(CARVALHO et al., 2003) and canine disease 
(OTRANTO et al., 2005; MAIA et al., 2012).
Immunochromathographic tests combine particular 
characteristics that are important during screenings. 
Otranto et al. (2005) have found this test to be a 
useful tool for the serological diagnosis of clinical 
and sub-clinical canine leishmaniasis. The authors 
have pointed out the speed, sensitivity, specificity 
and usefulness of the test both under field conditions 
and for surveys, in addition to its importance in 
routine veterinary practices requiring a minimum of 
equipment and training of the handler.
Canine visceral leishmaniasis immunocromatho-
graphic test (TR DPPTM Leishmaniose-visceral-canina- 
Bio-Manguinhos/FIOCRUZ kits) is a new assay 
manufactured by Bio-Manguinhos/FIOCRUZ/Brazil 
and Chembio Laboratories – USA. The device uses 
technology with dual path platform (DPPTM), 
insuring a high-sensitivity for the test and offering the 
result in about 15 minutes. The aim of this study was to 
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compare the performance of IRT with IFT, EIE assays 
(both manufactured by Bio-Manguinhos/FIOCRUZ) 
and DPT, as gold standard, in dogs suspected of being 
infected by L. (L.) chagasi (DE SANTIS et al., 2011) 
from Cuiabá, Mato Grosso state.  
Material and Methods
Study design: The present study has conducted 
with dogs domiciled in Cuiabá (Mato Grosso state) 
and captured by the Zoonosis Center Control (ZCC - 
Cuiabá), from July to November 2009. 
Sample selection: The selection adopted by ZCC 
included one or more of the following criteria: (i) 
animals with positive serology, by indirect fluorescent 
test (IFT) and/or enzyme-linked immunosorbent 
assay (EIE), previously held in the ZCC; (ii) dogs 
from neighboring areas where others were found to 
be infected and (iii) animals coming from homes 
or trapped in its vicinity where the ZCC had been 
collected phlebotomine. Dogs not meeting any of 
these criteria were not included in this study, resulting 
in the selection of 45 dogs.
Animals attributed data: Variables such as gender, 
breed and age were evaluated.   
Clinical examination: All animals were examined 
by veterinarians from ZCC for clinical signs 
compatible with CVL. Next, based on the results of the 
laboratory tests, the dogs were grouped according to 
the classification proposed by Paltrinieri et al. (2010), 
in following categories: (i) exposed, for dogs without 
evidence of parasite in tissues but with antibodies for 
Leishmania spp but clinically normal or having clinical 
signs associated with other diseases; (ii) infected, when 
the presence of Leishmania organisms are confirmed 
by parasitological or molecular methods and low-
titer specific antibodies are detected. Some of these 
animals can be healthy or not; (iii) sick, including 
dogs with positive results regardless of the tests and 
signs indicative of VL disease and (iv) severely sick, 
comprising dogs with severe clinical conditions and 
cytological findings. Dogs with none of the clinical 
or laboratory signs described above were considered 
negative.  
Laboratory tests: Kits of Canine Visceral 
Leishmaniasis immunocromathographic rapid 
test (IRT) (TR DPPTM Leishmaniose-visceral-
canina-Bio-Manguinhos/FIOCRUZ kits) (Bio-
Manguinhos/FIOCRUZ and Chembio Laboratories 
– USA), indirect fluorescent test (IFT) (IFI 
Canine Visceral Leishmaniasis Bio-Manguinhos/
FIOCRUZ) and enzyme- linked immunosorbent 
assay (EIE Canine Visceral Leishmaniasis Bio-
Manguinhos/FIOCRUZ). Serological techniques and 
immunochromathographic assay were performed 
according to the manufacturer’s instructions. The 
following criteria were adopted to classify the results 
as positive: IFT titers equal to or higher than 1:40, EIE 
readings over the cut-off and, for IRT, the emergence 
of two lines 15 minutes after buffer placement.
The direct parasitological test (DPT) was carried 
out by bone marrow aspiration to detect amastigotes 
in stained cytological smears (OLSSON et al., 2008) 
and was used as the gold standard. When necessary 
the animals were pre-anesthetized with Acepram® 
1% (acepromazine 0.1 mg/kg IM, 30 to 40 minutes 
before the assay) (MIRÓ et al., 2008; MÜLLER et al., 
2009). However, others, still agitated, required general 
anesthesia, with use of 25 mg/kg of sodic thiopental in 
order to perform the procedure. All of the laboratorial 
procedures were executed according to the Principles 
of Good Laboratory Practices (BRASIL, 2006) for the 
protection of the manipulator, sample and environment. 
Kappa Coefficient: Agreement (kappa coefficient) 
among the laboratory tests and the evaluation of 
positive and negative predictors were calculated. In 
order to identify the agreement between each test 
and the DPT gold standard the authors employed 
the set of Landis and Koch (1977) guidelines: values 
(k) < 0 as indicating no agreement; 0 – 0.20 as slight; 
0.21 – 0.40 as fair; 0.41 – 0.60 as moderate; 0.61 – 
0.80 as substantial, and 0.81 – 1 as almost perfect 
agreement. 
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 Ethics Committee: The project was submitted to 
the Use of Animals Committee (CEUA - FIOCRUZ) 
and duly approved (nº 0300/2006). 
Results
Distribution of variables, gender, age, breed and 
clinical findings: The results on gender, breed, age and 
clinical signs of the 45 selected dogs by ZCC-Cuiabá 
showed that 23 (51.1%) were male, 34 (75.5%) were 
mongrel and they had an estimated age under three 
years old, and in 20 (44.4%) clinical findings were 
related to the skin region, localized or generalized 
desquamative dermatitis (53.3%), alopecia (44.4%) 
and ulcerative dermatitis (40%).
Laboratory assays: Among the 45 studied animals, 
38 (84.4%) were positive for one of the four laboratory 
analyses carried out. Direct parasitological test (DPT) 
was used as gold standard and was prepared for all 
45 animals and 16 (42.1%) were positive. When 
commercial kits for serological methods have been 
evaluated, IFT has proved to present higher frequency, 
38 (100%) serum samples have been achieved titers 
equal to or above 1:40, as recommended by the kit’s 
instructions. IRT and EIE test generated positive 
responses: 21 (55.3%) and 19 (50.0%) samples, 
respectively (Table 1).
According to the dogs infected by L. (L.) chagasi 
classification, proposed by Paltrinieri et al. (2010), 
among the 38 (100%) positive animals, 10 (26.3%) 
have been accounted as exposed or infected and 
18 (47.4%) as sick; none was classified as a severely 
sick dog. Among the regarded accounted as sick and 
exposed animals, all of them were detected by IFT 
(Table 1). 
Analysis of agreement among the serological and 
parasitological tests: Benchmarks were then between 
each serological technique and the DPT gold standard 
(Table 2). All IFT positive sera have been also DPT 
positive, total of 16 (100%), followed by IRT and EIE, 
13 (81.3%) and 10 (62.5%), respectively. Sensibility 
and specificity were calculated for each test. The results 
showed high sensitivity of 81.3% and 100% for IRT 
and IFT, respectively and moreover 65.5% obtained in 
EIE However, the specificity was lower, respectively, 
72.4%, 69.0% and 24.1% for IRT, EIE and IFT. 
Our results have confirmed all negatives DPT were 
also in IFT. Indeed the negative predictive values were 
100% between the gold standard and IFT and the positive 
predictive value detected was low, 42.1% (Table 2).  
Kappa index: Kappa coefficient (k) was 
determinated (LANDIS; KOCH, 1977) among each 
test and the DPT. The best agreement was IRT: k equal 
Table 1 - Clinical classification matched with positive and negative results of laboratory assays in 
38 samples from dogs screened by ZCC-Cuiabá, from July to November of 2009
Clinical Approach (N)                                     Laboratory assays*
 DPT (%) IRT (%) IFT** (%) EIE (%)
EXPOSED (10) 00 00 10 (26.3) 01 (5.3)’
INFECTED (10) 02 (12.5) 05 (23.8) 10 (26.3) 04 (21.1)
SICK (18) 14 (87.5) 16 (76.2) 18 (47.4) 14 (73.7)
TOTAL 16 21 38 19
38  (42.1) (55.3) (100) (50.0)
* Seven (15.56%) were negative in all laboratory assays
** Positive results for titers equal or above 1:40
DPT – Direct Parasitological Test
IRT - Immunocromathographic Rapid Test (TR DPPTM Leishmaniose Visceral Canina - Manguinhos/FIOCRUZ and 
Chembio Laboratories/USA)
IFT – Indirect Fluorescent Test (IFI Canine Visceral Leishmaniasis - Bio-Manguinhos/FIOCRUZ)
EIE– – Enzyme-linked Immunosorbent Assay (EIE Canine Visceral Leishmaniasis – BioManguinhos/FIOCRUZ)
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Table 2 -  Agreement estimated among the results obtained from DPT, the golden standard and serological tests, as well the 
respective rate of sensibility and specificity, positive and negative predictive values and the kappa index with data 
interpretation from 38 studied dogs screened by ZCC-Cuiabá, between July and November of 2009 
ASSAYS DPT Sensibility Specificity PPV NPV Kappa Value
 (+)      (-)  (%) (%) (%) (%) (interpretation)
IRT      (+) 13      08
             (–) 03      21 81.3 72.4 61.9 87.5 0.50
Total 16      29     (substantial)
EIE      (+) 10      09
            (–) 06      20 62.5 69.0 52.6 76.9 0.13
Total 16      29     (slight)
IFT**  (+)      16      22
            (–) 00      07 100.0 24.1 42.1 100.0 0.18
Total 16      29      (slight)
** Positive results for titers equal or above 1:40
CI - 95%
DPT  – Direct Parasitological Test
IRT - Immunochromatographic Rapid Test (TR DPPTM Leishmaniose Visceral Canina - Manguinhos/FIOCRUZ and Chembio Laboratories/USA)
IFT  – Indirect Fluorescent Test (IFI Canine Visceral Leishmaniasis - Bio-Manguinhos/FIOCRUZ)
EIE– – Enzyme-linked Immunosorbent Assay (EIE Canine Visceral Leishmaniasis – Bio-Manguinhos/FIOCRUZ)
PPV – Positive Predictive Value
NPV – Negative Predictive Value
to 0.50 (substantial) and 0.18 and 0.1.3 (slight) for IFT 
and EIE, respectively (Table 2).
Discussion and Conclusions
The dogs studied were from Cuiabá and they 
were collected or taken to the Zoonosis Control 
Center due to the possibility of being harboring the 
etiological agent. CVL is a systemic disease, but it is 
not clear yet which factors may influence resistance 
or susceptibility. Gender (TRAVI; OSORIO; MELBY, 
2002), breed (FERROGLIO; VITALE, 2006) and age 
(CARDOSO et al., 2004) are some of the possibilities 
that may suggest an infection prognosis. In our study, 
no gender differences were observed (48.9% and 
51.1% for females and males, respectively); about the 
breed of the studied dogs, 75% were mongrels. The 
disease prevalence was higher in groups of up to three 
years old, 34.4% were considered sick, perhaps due 
to the low immune response, usually seen in this age 
group; despite the small numbers of dogs examined, 
data were similar to Cardoso et al. (2004) findings.   
Canine disease is also marked by clinical signs, 
which are common to several other pathologies 
inspiring an accurate diagnosis. Among the main 
clinical signs described by Baneth et al. (2008) for 
CVL, our study has detected desquamation (53.3%), 
followed by alopecia (44.4%) and ulcers (40%).
The Brazil’s Ministry of Health (2006) advocates the 
IFT and EIE kits (Bio-Manguinhos/FIOCRUZ) for use 
not only in individual diagnosis but also in field surveys. 
Moreover, at new transmission areas, the parasitological 
confirmation has also been required, by means of bone 
marrow aspirative punction in order to prepare smears 
and further species identification (BRASIL, 2006). In 
our study, DPT was used as the reference method, due 
to its ability to identify the Leishmania spp parasite. 
However, it seems to be an invasive assay that requires 
skilled laboratory technicians, besides it does not show 
good sensitivity (TAFURI et al., 2001).  Our findings 
have showed of 16 (42.1%) dogs DPT positive, 14 
(87.5%) were classified as sick. Indeed the likelihood 
of these animals have high parasite load permitted its 
recognition on bone marrow smears. 
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The high sensitivity of IFT was also confirmed in the 
45 samples studied, all 38 animals classified as exposed, 
infected or sick being positive to IFAT with titers 
between 1:40 and 1:1280. None of the other tests used in 
the study showed a similar performance. Probably due 
to low cut off recommended by the kit’s instructions. 
Boarino et al. (2008) considered 1:40 cut off as doubtful. 
However, the IFAT positive predictive value was lower, 
42.1%, when compared with DPT. Indeed, IFAT is not 
able to distinguish between CVL progression states and 
it seems that may not be useful as a marker of disease. 
The group of dogs classified as exposed displayed clinical 
signs consistent with other diseases (FERROGLIO et 
al., 2007; FIGUEIREDO et al., 2010). 
Furthermore, it might be more prudent to include 
differential diagnoses before a conclusive diagnosis 
that may follow the domestic dog elimination. This 
procedure has not been able to produce elimination 
or even the reduction in the human cases incidence 
satisfactory results, which highlights the absence of 
strong evidence for a significant impact (ROMERO; 
BOELAERT, 2010).
The positive result obtained by EIE (Bio-
Manguinhos/FIOCRUZ) assay has shown a weak 
performance. The sensibility and specificity were the 
lowest ones, 62.5% and 69.0%, respectively. Actually 
this kit was also tested by other authors (LIRA et al., 
2006; BISUGO et al., 2007) with different results, 
emphasizing the inconsistent results produced by EIE 
(PORROZZI et al., 2007). However, the serological 
and parasitological methods implementation requires 
special conditions, such as laboratory infrastructure 
and trained staff. In addition, it takes a long time to 
deliver the results. Thus, given the complexity of CVL 
diagnosis, laboratory methods easier to perform, 
interpret and rapid results are increasingly required.  
Immunochromathographic rapid test (IRT) (TR 
DPPTM Leishmaniose-visceral-canina-Bio-Manguinhos/ 
FIOCRUZ kits) was developed by Bio-Man-guinhos/
FIOCRUZ in partnership with Chembio (USA) for the 
diagnosis of CVL. The results have showed a higher 
sensibility (81.3%) and intermediate specificity (72.4%). 
IRT has allowed the identification of 5 (50.0%) infected 
and 16 (88.9%) sick dogs, but failed, as expected, to spot 
the exposed animals. Still, the new assay has presented 
the best result for the positive and negative predictive 
values, 61.9% and 87.5%, respectively, with a substantial 
degree of agreement (k = 0.50), different from the two 
others assays as slight for both IFT (k = 0.18) and EIE 
(k = 0.13). IRT has been ensured better results than IFT 
and EIE both recommended by the Brazilian Health 
Ministry and guide the selection, sometimes wrongly, 
of animals for disposal.
In this study, the results showed that the combination 
of the dual path platform, with selected joining 
recombinant antigens of L. (L.) chagasi, has allowed 
to the device IRT to be a good infection and disease 
predictor for CVL, besides being a simple procedure, 
easy to handle, rapid and adapted for use in both the 
field and the laboratory. 
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